Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glioblastoma × Temozolomide × Clear all

Phase

Phase 2 136 Phase 1 94 Phase 1/2 60 Phase 3 35 Phase 2/3 8 Phase NA 6 Phase EARLY_PHASE1 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

trametinib 1 dabrafenib 1 Temozolomide 1 Radiotherapy 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed

99 enrolled 15 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡